270 related articles for article (PubMed ID: 21951325)
1. Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.
Raskin P; Heller S; Honka M; Chang PC; Boss AH; Richardson PC; Amin N
Diabetes Obes Metab; 2012 Feb; 14(2):163-73. PubMed ID: 21951325
[TBL] [Abstract][Full Text] [Related]
2. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.
Skyler JS; Jovanovic L; Klioze S; Reis J; Duggan W;
Diabetes Care; 2007 Mar; 30(3):579-85. PubMed ID: 17327324
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
Skyler JS; Hollander PA; Jovanovic L; Klioze S; Krasner A; Riese RJ; Reis J; Schwartz P; Duggan W;
Diabetes Res Clin Pract; 2008 Nov; 82(2):238-46. PubMed ID: 18824271
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial.
Moses RG; Bartley P; Lunt H; O'Brien RC; Donnelly T; Gall MA; Vesterager A; Wollmer P; Roberts A
Diabet Med; 2009 Mar; 26(3):260-7. PubMed ID: 19317821
[TBL] [Abstract][Full Text] [Related]
5. Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.
Barnett AH; Lange P; Dreyer M; Serdarevic-Pehar M;
Int J Clin Pract; 2007 Oct; 61(10):1614-25. PubMed ID: 17877648
[TBL] [Abstract][Full Text] [Related]
6. [Perspectives of inhaled insulin treatment].
Chodorowski Z; Sein Anand J
Przegl Lek; 2007; 64(4-5):365-7. PubMed ID: 17724916
[TBL] [Abstract][Full Text] [Related]
7. Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy.
Cefalu WT; Bohannon NJ; Edwin Fineberg S; Teeter JG; Schwartz PF; Reis JM; Krasner AS
Curr Med Res Opin; 2008 Nov; 24(11):3073-83. PubMed ID: 18828959
[TBL] [Abstract][Full Text] [Related]
8. A review of inhaled technosphere insulin.
Neumiller JJ; Campbell RK; Wood LD
Ann Pharmacother; 2010; 44(7-8):1231-9. PubMed ID: 20516362
[TBL] [Abstract][Full Text] [Related]
9. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
Mathieu C
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary function changes related to acute and chronic administration of inhaled insulin.
Hegewald M; Crapo RO; Jensen RL
Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S93-S101. PubMed ID: 17563309
[TBL] [Abstract][Full Text] [Related]
11. Age-associated changes in pulmonary function: a comparison of pulmonary function parameters in healthy young adults and the elderly living in Shanghai.
Ren WY; Li L; Zhao RY; Zhu L
Chin Med J (Engl); 2012 Sep; 125(17):3064-8. PubMed ID: 22932182
[TBL] [Abstract][Full Text] [Related]
12. AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability.
Rave K; de la Peña A; Tibaldi FS; Zhang L; Silverman B; Hausmann M; Heinemann L; Muchmore DB
Diabetes Care; 2007 Jul; 30(7):1777-82. PubMed ID: 17456839
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.
Pfützner A; Forst T
Expert Opin Drug Deliv; 2005 Nov; 2(6):1097-106. PubMed ID: 16296812
[TBL] [Abstract][Full Text] [Related]
14. Technosphere insulin (Afrezza): a new, inhaled prandial insulin.
Nuffer W; Trujillo JM; Ellis SL
Ann Pharmacother; 2015 Jan; 49(1):99-106. PubMed ID: 25313261
[TBL] [Abstract][Full Text] [Related]
15. Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents.
Rosenstock J; Franco D; Korpachev V; Shumel B; Ma Y; Baughman R; Amin N; McGill JB;
Diabetes Care; 2015 Dec; 38(12):2274-81. PubMed ID: 26253730
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis.
Pittas AG; Westcott GP; Balk EM
Lancet Diabetes Endocrinol; 2015 Nov; 3(11):886-94. PubMed ID: 26341170
[TBL] [Abstract][Full Text] [Related]
17. Changes in pulmonary function up to 10 years after locoregional breast irradiation.
Erven K; Weltens C; Nackaerts K; Fieuws S; Decramer M; Lievens Y
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):701-7. PubMed ID: 21398052
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A
J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258
[TBL] [Abstract][Full Text] [Related]
20. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: safety.
Brain JD
Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S14-8. PubMed ID: 16135134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
